Xuanzhu Biopharmaceutical -H (2575.HK) traded down -0.6 % during a 24 hours period ending at 03:32 PM Central Europe on Monday 26th. One Xuanzhu Biopharmaceutical -H stock can currently be bought for about HKD 8.48 on popular exchanges. Current supply of Xuanzhu Biopharmaceutical -H stocks is 517.6 mn. Xuanzhu Biopharmaceutical -H has a current market capitalization of HKD 4.3 bn and approximately HKD 6.2 mn worth of Xuanzhu Biopharmaceutical -H was traded on exchanges in the last 24 hours. Since last month end, Xuanzhu Biopharmaceutical -H has traded -0.54 % down. Simple moving average of last 200 days is at HKD 28.27. The highest price of past 52 weeks was recorded at HKD 96.9 on 12/12/2025. 52 weeks low was at HKD 8 on 09/16/2026.
Here is how related stocks have performed in the past 24 hours:
Shenzhen Bauing Contructio (002047.SZ) traded flat 0 % and now trades at CNY 2.8. Current market capitalisation for Shenzhen Bauing Contructio is CNY 4.4 bn. Shenzhen Bauing Contructio has a current price to earnings ratio of 80.11.
Shenzhen Minglida Precisio (301268.SZ) traded flat 0 % and now trades at CNY 11.11. Shenzhen Minglida Precisio has a market capitalisation of CNY 4.4 bn.
Fujian Raynen (603933.SS) traded flat 0 % and now trades at CNY 20.37. Fujian Raynen has a market capitalisation of CNY 4.4 bn. Fujian Raynen has a current price to earnings ratio of 66.79. On October 26, 2026, Fujian RayeN Technology Co., Ltd. saw its shares experience a sharp rebound after a period of decline. The company’s stock opened within a tight range but gained momentum during the trading session, ultimately reaching a new high. The rally was driven largely by market sentiment around the broader robotics and artificial‑intelligence sector, which was in the midst of a strong upswing following recent industry events. Analysts noted that while the company’s core business remains focused on steel and cable manufacturing, its emerging robotics activities have attracted attention from investors. The upward movement reflected a renewed confidence in the firm’s potential to expand its product line within the growing robotics ecosystem, with investors weighing the company’s current development stage against the broader sector’s momentum.
Hangzhou Ags Medtech Lt (688581.SS) traded flat 0 % and now trades at CNY 55.76. Hangzhou Ags Medtech Lt has a market capitalisation of CNY 4.4 bn. On October 23, 2026, financing activity across the Shanghai Stock Exchange remained robust, with 3,870 stocks receiving margin purchases. The data highlighted significant inflows into a range of names, including both large‑cap technology and industrial players. While the article lists the top recipients of financing, it does not mention HANGZHOU AGS MEDTECH CO LT. No specific information about the company’s financial performance, share price movement or corporate developments was provided in the source. Consequently, there is no basis for reporting any direct impact on HANGZHOU AGS MEDTECH CO LT in this context.
Tech-bank Food (002124.SZ) traded flat 0 % and now trades at CNY 1.93. Current market capitalisation for Tech-bank Food is CNY 4.4 bn. TECH‑BANK FOOD CO LTD reported that its latest quarterly results show continued revenue growth and profitability, though the pace of earnings expansion has moderated compared with the previous period. The company’s earnings before non‑financial items remain solid, reflecting stable demand in its core markets. While overall profitability is positive, the growth rate of net profit has eased, indicating a normal adjustment cycle. Management noted that the company’s supply chain and cost controls remain effective, supporting future performance. Market observers are watching the company’s financial trajectory closely as part of a broader trend of slowing earnings momentum among leading firms in the sector.